Envista Holdings Corporation $NVST Stock Holdings Lessened by Clarkston Capital Partners LLC

Clarkston Capital Partners LLC trimmed its stake in shares of Envista Holdings Corporation (NYSE:NVST) by 8.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,317,255 shares of the company’s stock after selling 386,075 shares during the period. Envista comprises about 1.9% of Clarkston Capital Partners LLC’s holdings, making the stock its 17th biggest holding. Clarkston Capital Partners LLC’s holdings in Envista were worth $87,942,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of NVST. GAMMA Investing LLC raised its holdings in shares of Envista by 34.3% during the 3rd quarter. GAMMA Investing LLC now owns 2,498 shares of the company’s stock valued at $51,000 after purchasing an additional 638 shares in the last quarter. Claret Asset Management Corp lifted its position in shares of Envista by 6.5% in the second quarter. Claret Asset Management Corp now owns 11,827 shares of the company’s stock worth $231,000 after buying an additional 724 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after acquiring an additional 949 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in shares of Envista by 317.6% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after acquiring an additional 1,026 shares in the last quarter. Finally, Vanguard Personalized Indexing Management LLC increased its holdings in shares of Envista by 5.9% during the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 21,283 shares of the company’s stock valued at $434,000 after acquiring an additional 1,183 shares during the last quarter.

Envista Price Performance

NYSE:NVST opened at $26.82 on Monday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.38. The company has a 50-day moving average of $25.79 and a 200-day moving average of $22.44. Envista Holdings Corporation has a 52 week low of $14.22 and a 52 week high of $30.42. The company has a market capitalization of $4.40 billion, a price-to-earnings ratio of 95.79, a PEG ratio of 1.83 and a beta of 0.95.

Envista (NYSE:NVST) last announced its quarterly earnings results on Thursday, February 5th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.During the same period last year, the business posted $0.24 EPS. The company’s revenue was up 15.0% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities research analysts anticipate that Envista Holdings Corporation will post 1 earnings per share for the current fiscal year.

Insider Activity at Envista

In other Envista news, SVP Mischa Reis sold 9,675 shares of the stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total transaction of $290,250.00. Following the sale, the senior vice president owned 32,382 shares of the company’s stock, valued at $971,460. This represents a 23.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Weiss Ratings raised shares of Envista from a “sell (d)” rating to a “hold (c-)” rating in a research report on Tuesday, February 17th. Leerink Partners set a $35.00 price objective on shares of Envista and gave the stock an “outperform” rating in a report on Friday, February 6th. Robert W. Baird set a $30.00 target price on shares of Envista in a research note on Friday, February 6th. Wells Fargo & Company lifted their target price on shares of Envista from $21.00 to $26.00 and gave the stock an “equal weight” rating in a report on Friday, February 6th. Finally, UBS Group boosted their target price on shares of Envista from $22.00 to $25.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 3rd. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, Envista currently has a consensus rating of “Moderate Buy” and a consensus price target of $27.75.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.